What Vinay Prasad thinks about benchmarks
Hematologist-oncologist and professor of epidemiology and biostatistics at UCSF. Director of the FDA's Center for Biologics Evaluation and Research from 2025 to 2026. Writes about cancer drugs, clinical-trial evidence and health policy; co-founder of Sensible Medicine.
Vinay Prasad did not write this page.
We collected these quotes from things they published elsewhere, and every quote links to where it was said. They have no account here and have not endorsed this site. Quotes are word for word; the short line under each one is our own restatement, not their wording. Their own site. Is this you? Claim it or ask us to remove it. Or tell us what is wrong here.
Filter benchmarks · Newest first
Only Vinay Prasad on benchmarks. See everyone on benchmarks
2 dated positions, 2026, in their own words. Our reading of what Vinay Prasad has said — not written or endorsed by them.
-
Our readingElon Musk has overstated delivery milestones for all his products but does eventually deliver.
Their wordsI actually think SpaceX will be a successful corporation. But we have to admit he has overstated the delivery milestones of all his products. But yet he does deliver eventually.
↗AI researchers take up smoking/ Elizabeth Holmes Film/ Moderna Stockyoutube.com 9th of 20 in this recording
- 3 weeks earlier
-
Our readingThe Nobel prizes miss the mark.
Their wordsIt's no secret that I think the Nobel prizes misses the mark.
↗Vinay Prasad’s Observations and Thoughtsdrvinayprasad.com 1st of 3 in this piece